TAK-536

DRUG3 trials

Sponsors

Takeda

Conditions

Healthy VolunteersHypertensionJapanese Healthy Adult Male Participants

Phase 1

A Phase 1, Bio-equivalence Study of TAK-536 Pediatric Formulation

CompletedNCT03042299

TakedaJapanese Healthy Adult Male Participants

Start: 2017-02-10End: 2017-03-11Updated: 2018-11-14

A Phase 1 Food Effect Study of Azilsartan (TAK-536) Pediatric Formulation

CompletedNCT03434977

TakedaHealthy Volunteers

Start: 2018-02-14End: 2018-03-11Updated: 2019-06-10

Phase 3

A Study of TAK-536 in Children From 2 to Less Than 6 Years Old With High Blood Pressure

CompletedNCT04668157

TakedaHypertension

Start: 2021-05-17End: 2023-12-28Updated: 2024-12-09